Blur, Facebook and the First Amendment

The opinions expressed here are my own, and do not necessarily represent the views of my current employer. This disclaimer will make more sense as you read on.

Ten years ago, the book Blur: The Speed of Change in the Connected Economy was published. Blur looked at how three factors in the wired world—speed (instant communication and computation), connectivity (shrinking space between people, ideas and things) and intangibles (value without physical goods)—were increasing the rate of change in business and the world at large. This included the blurring of boundaries between work and home, made possible in part by wireless networks and always-on connectivity to the Internet.

Fast forward a decade, and the average knowledge worker now contends with evolving technologies and societal trends that make the 1999 notion of “blur” seem quaint. Compartmentalizing home and work is extremely difficult for most of us. We answer work emails while watching our kids' soccer games on Saturdays, yet we also manage many personal tasks using a company-issued PC while in the office.

Lately, the more interesting blur for me is that one can never shed his work persona online. When people express themselves on personal blogs, Facebook and LinkedIn, some would say that they are acting as de facto, yet unauthorized, company spokespeople. If one works for pharma and chats online about gardening or photography, that's probably OK. But if that same person decides to offer opinions about the industry, FDA, the practice of marketing or some other aspect of his job—without disclosing any specifics about his company—is that a violation of his employee contract?

Recently, a colleague of mine parted ways with his employer. He was a product manager by day and a relatively popular YouTube comedian at night, making his employer uncomfortable. When he ventured into making personal videos parodying the practice of marketing, his First Amendment rights collided with his employee Code of Conduct. Other conversations I've had with agency professionals confirms that this is becoming an issue for any public company concerned about its image, and its liability for what employees say on their “own time.”

Joe Shields is product director, Enbrel, at Wyeth
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.